Oramed Pharmaceuticals Inc. is a development-stage pharmaceutical company. The Company is engaged in the research and development of pharmaceutical solutions, including an orally ingestible insulin capsule or tablet to be used for the treatment of individuals with diabetes, use of orally ingestible capsules, tablets or pills for delivery of other polypeptides. The Company owns oral dosage form drug portfolio, it is, on an on-going basis, considering in-licensing and other means of obtaining additional technologies to complement and/or expand the product portfolio. The Company�s products include ORMD-0801 - Oral Insulin Capsule and ORMD-0901 - Oral Exenatide. The Company focuses to conduct research and development on the technology covered by the patent application Methods and Composition for Oral Administration of Proteins.